- By Benjamin Greene
- Posted 11/28/2016 11:01:59 AM
Researchers at Duke University Medical Center are bringing new hope to the treatment of autism. They recently concluded a preliminary clinical trial with 25 autistic children ages two through six who were infused with their own cord blood and followed for a year. The results are exciting, enabling them to move to a full-blown phase two study. If the results follow what they have been seeing so far, it will spawn a better, new way to treat autism.